CaV3.2, Monoclonal Antibody
Partner: Aviva Systems Biology
| Applications: | WB, IHC, ICC, IF, IP, AM |
| Species Reactivity: | Human, Mouse, Rat |
| Dilutions: | WB (1:1000), IHC (1:1000), ICC/IF (1:100); optimal dilutions for assays should be determined by the user. |
| Immunogen: | Fusion protein amino acids 1019-1293 (II-III loop) of human Cav3.2 |
| Purification: | Protein G Purified |
| Conjugation: | Unconjugated |
| Description: | CaV3.2 is a protein which in humans is encoded by the CACNA1H gene. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (1, 2). Studies also suggest that the up-regulations of CaV3.2 may participate in the progression of prostate cancer toward an androgen-independent stage (3). |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
